Happy New Year,

I hope everybody is ready for a great 2025 !

I'll start my message/question by defining 2 different ways of coding a simple 
power relationship between body weigh on clearance.

  *
Coding 1

MU_1 = THETA(1) + THETA(2) * LOG(WGT/70)
CL = EXP( MU_1 + ETA(1) )

  *
Coding 2

MU_1 = THETA(1)
CL = EXP( MU_1 + ETA(1) ) * ( WGT/70 )**THETA(2)

The reference and training materials for NONMEM clearly indicate that MU 
variables should be time invariant within occasions and recommend using coding 
2 when body weight is time varying. Nevertheless, it is possible for an analyst 
to use coding 1. As far as I can tell from some limited testing, this is not a 
"fatal" error. Either with FOCE(I) or SAEM/IMP, NONMEM reports a warning but 
performs the model optimization. The table outputs also report CL as a time 
varying variable changing as body weight changes.

So my questions are the following: when coding 1 is used and body weight is 
time varying, what is NONMEM actually doing during model optimization? Does 
NONMEM internally create occasions to break the records by interval of constant 
body weight and constant MU1? Alternatively, does NONMEM internally calculate 
an average of MU1? Something entirely different? What's the risk taken by an 
analyst when using coding 1 versus coding 2?

Thank you in advance for you input



Sébastien Bihorel
Director, Quantitative Pharmacology
+1 914-648-9581
sebastien.biho...@regeneron.com



Regeneron - Internal

******************************************************************** 
This e-mail and any attachment hereto, is intended only for use by the 
addressee(s) named above and may contain legally privileged and/or confidential 
information. If you are not the intended recipient of this e-mail, any 
dissemination, distribution or copying of this email, or any attachment hereto, 
is strictly prohibited. If you receive this email in error please immediately 
notify me by return electronic mail and permanently delete this email and any 
attachment hereto, any copy of this e-mail and of any such attachment, and any 
printout thereof. Finally, please note that only authorized representatives of 
Regeneron Pharmaceuticals, Inc. have the power and authority to enter into 
business dealings with any third party. 
********************************************************************

Reply via email to